共 205 条
[1]
Parihar MS(2004)Alzheimer’s disease pathogenesis and therapeutic interventions Journal of Clinical Neuroscience 11 456-467
[2]
Hemnani T(2003)Treatment of Alzheimer's disease; current status and new perspectives Lancet Neurol 2 539-547
[3]
Scarpini E(2012)Acetylcholinesterase inhibitors: a patent review (2008—present) Expert Opin Ther Pat 22 871-886
[4]
Schelterns P(1997)Drug treatments for Alzheimer's disease Br Med J 314 693-694
[5]
Feldman H(1999)Cholinergic therapy in dementia Acta Neurol Scand Suppl 149 42-45
[6]
Pohanaka M(1999)Rivastigmine, a brain region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status Expert Opin Investig Drugs 8 1673-1682
[7]
Kelly CA(2000)Galantamine: a review of its use in Alzheimer's disease Drugs 60 1095-1122
[8]
Harvey RJ(2019)Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity Life Sci 222 112-116
[9]
Cayton H(2015)Plant alkaloids as drug leads for Alzheimer's disease Neurochem Int 89 260-270
[10]
Whitehouse PJ(2019)Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: a new class of cholinesterase inhibitor for Alzheimer’s disease Bioorg Chem 88 102947-223